Brady W. Dougan - 13 Oct 2021 Form 4 Insider Report for Humacyte, Inc. (HUMA)

Role
Director, 10%+ Owner
Signature
/s/ Brady W. Dougan by Dale A. Sander as Attorney-in-Fact
Issuer symbol
HUMA
Transactions as of
13 Oct 2021
Net transactions value
$0
Form type
4
Filing time
15 Oct 2021, 15:40:06 UTC
Previous filing
27 Aug 2021
Next filing
20 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HUMA Stock Options (right to buy) Award $0 +8,500 $0.000000 8,500 13 Oct 2021 Common Stock 8,500 $10.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The first 25% of the option becomes exercisable on October 13, 2022, after which 1/36 of the option will become exercisable on the 13th of each month through October 13, 2025.